Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): Implications for future vaccination strategies

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Ardanuy, Carmen ^a,b   Marimón, José María ^b,c   Calatayud, Laura ^a,b   Giménez, Montserrat ^b,d   Alonso, Marta ^b,c   Grau, Immaculada ^a,b   Pallarés, Román ^a,b   Pérez Trallero, Emilio ^b,c   Liñares, Josefina ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL DONOSTIA   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; PNEUMOCOCCAL CONJUGATE VACCINE 13; PNEUMOCOCCUS VACCINE; TETRACYCLINE; UNCLASSIFIED DRUG;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; OUTCOME ASSESSMENT; PNEUMOCOCCAL INFECTION; PNEUMONIA; PROSPECTIVE STUDY; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADULT; AGED; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; SEROTYPING; SPAIN; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84865172640     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043619     Document Type: Article

References (33)

1. Musher DM, ((1992)) Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 14:: 801--807.
2. Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices ((2010)) Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep 59:: 1102--6.
3. Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, et al. ((2009)) Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol 47:: 1012--20.
4. Liñares J, Ardanuy C, Pallares R, Fenoll A, ((2010)) Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect 16:: 402--10.
5. Calatayud L, Ardanuy C, Tubau F, Rolo D, Grau I, et al. ((2010)) Serotype and genotype replacement among macrolide-resistant invasive pneumococci in adults. Mechanisms of resistance and association with different transposons. J Clin Microbiol 48:: 1310--6.
6. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, et al. ((2007)) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis196:: 1346--1354.
7. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, et al. ((2006)) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354:: 1455--1463.
8. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. ((2003)) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 348:: 1737--1746.
9. Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, et al. ((2005)) Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 41:: 21--29.
10. Pérez-Trallero E, Marimon JM, Ercibengoa M, Vicente D, Pérez-Yarza EG, ((2009)) Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis 28:: 731--738.
11. Ardanuy C, Tubau F, Pallares R, Calatayud L, Domínguez MA, et al. ((2009)) Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis 48:: 57--64.
12. Miller E, Andrews NJ, Waight PA, Slack MP, George RC, ((2011)) Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 11:: 760--768.
13. Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, et al. ((2005)) Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294:: 2043--2051.
14. Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, et al. ((2007)) Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 197:: 1016--1027.
15. Brueggemann AB, Pai R, Crook DW, Beall B, ((2007)) Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 3:: 1628--1636.
16. Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro J, García-de Miguel MJ, et al. (2012) First impact data of 13-valent pneumococcal conjugate vaccine (PCV13) on invasive pneumococcal disease in children in Madrid, 2010-2011 (Heracles study). 8th. International Symposium on Pneumococci and Pneumococcal Diseases. Poster number 189.
17. Andrews N, Kaye P, Slack M, George R, Miller E (2012) Effectiveness of the 13 valent pneumococcal conjugate vaccine against IPD in England and Wales. 8th. International Symposium on Pneumococci and Pneumococcal Diseases. Poster number 148.
18. M. van der Linden, M Imöhl (2012) Effects of immunization with higher valent pneumococcal conjugate vaccines in German children on numbers of reported IPD cases. 8th. International Symposium on Pneumococci and Pneumococcal Diseases. Poster No 199.
19. Sá-Leão R, Pinto F, Aguiar S, Nunes S, Carriço JA, et al. ((2011)) Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype. J Clin Microbiol 49:: 1369--1375.
20. Beall B, McEllistrem MC, Gertz RE Jr, Wedel S, Boxrud DJ, et al. ((2006)) Active Bacterial Core Surveillance Team. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J Clin Microbiol 44:: 999--1017.
21. Grall N, Hurmic O, Al Nakib M, Longo M, Poyart C, et al. ((2011)) Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine. Eur J Clin Microbiol Infect Dis 30:: 1511--1519.
22. Obando I, Muñoz-Almagro C, Arroyo LA, Tarrago D, Sanchez-Tatay D, et al. ((2008)) Pediatric parapneumonic empyema, Spain. Emerg Infect Dis 14:: 1390--1397.
23. Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, et al. ((2007)) Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 26:: 468--472.
24. Choi EH, Kim SH, Eun BW, Kim SJ, Kim SH, et al. ((2008)) Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 14:: 275--281.
25. Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, et al. ((2009)) Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother 64:: 507--510.
26. Pantosti A, Gherardi G, Conte M, Faella F, Dicuonzo G, et al. ((2002)) A novel, multiple drug-resistant, serotype 24F strain of Streptococcus pneumoniae that caused meningitis in patients in Naples, Italy. Clin Infect Dis 35:: 205--208.
27. Cooper D, Yu X, Sidhu M, Nahm MH, Fernsten P, et al. ((2011)) The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A. Vaccine 29:: 7207--7211.
28. Fenoll A, Jado I, Vicioso D, Casal J, ((1997)) Dot blot assay for the serotyping of pneumococci. J Clin Microbiol 35:: 764--766.
29. Marimon JM, Monasterio A, Ercibengoa M, Pascual J, Prieto I, et al. ((2010)) Antibody microarray typing, a novel technique for Streptococcus pneumoniae serotyping. J Microbiol Methods 80:: 274--80.
30. Clinical and Laboratory Standard Institute (2009) Methods for dilution antimicrobial susceptibility test for bacteria that growth aerobically; 8th ed. Approved standard. CLSI/NCCLS document M7-A8. Wayne, Pa: Clinical and Laboratory Standards Institute. Vol 29.
31. Clinical Laboratory Standard Institute (2011) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-first Informational Supplement. CLSI/NCCLS document M100-S21. Wayne, Pa: Clinical and Laboratory Standards Institute. Vol 31.
32. McGee L, McDougal L, Zhou J, Spratt BG, Tenover FC, et al. ((2001)) Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol 39:: 2565--2571.
33. Enright MC, Spratt BG, ((1998)) A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:: 3049--3060.